Engrail closes $157M series B, fueled by investors’ renewed interest in neuropsychiatry March 19, 2024
A Jewish American and a Palestinian American are tackling science’s toughest challenges February 23, 2024
KalVista pill reduces swelling symptoms caused by genetic disease, achieving goal of late-stage study February 23, 2024
Weeks after $213M launch, Tome acquires a Berkeley gene editing startup for DNA ligase technology January 2, 2024